On August 29, 2025, Procter & Gamble reported Q4 2025 earnings that exceeded analyst estimates, with adjusted EPS of US$1.48 and revenues of US$20.89 billion, and announced strong forward guidance for fiscal 2026.
P&G’s announcement highlights management’s confidence in delivering ongoing organic sales and free cash flow growth, despite the challenging business backdrop.
We'll examine how Procter & Gamble's robust earnings report and upbeat outlook could shape its investment narrative for...
Crown Castle recently announced plans to divest its fiber division by mid-2026 and appointed a new CEO to lead the company’s next chapter.
This move signals a shift toward focusing on core tower infrastructure, which many analysts believe could enhance operational efficiency and shareholder value.
We’ll explore how the intention to sell the fiber business could shape Crown Castle’s investment case moving forward.
Outshine the giants: these 25 early-stage AI stocks could fund your...
Paycom Software (PAYC) just made some major moves in its executive team, announcing new leadership roles focused on technology and automation. Shane Hadlock is taking on a dual role as both chief client officer and chief technology officer, while Rachael Gannon has been promoted to chief automation officer, effective August 18, 2025. The company also named Brad Smith as senior technical strategist. These changes indicate that Paycom is emphasizing both innovation and client experience,...
Johnson & Johnson recently announced that 10-year clinical trial results presented at the European Society of Cardiology Congress and published in the New England Journal of Medicine found that routine use of the Impella CP heart pump in patients with heart attacks complicated by cardiogenic shock led to a significant and increasing absolute reduction in mortality compared to standard care.
The findings position Impella CP as the first mechanical circulatory support device proven in a...
CVS Health recently announced it will not offer the 2025–2026 COVID-19 vaccine in 16 states and Washington, D.C., due to evolving regulatory requirements that limit vaccines to those endorsed by the Advisory Committee on Immunization Practices (ACIP).
This restriction may significantly reduce vaccine access ahead of the upcoming respiratory virus season, raising operational and business challenges for pharmacy providers like CVS.
We'll examine how CVS Health's decision to stop administering...
Prudential Financial (PRU) has made some moves that could have investors pausing to reassess their outlook. The company rolled out enhancements to its EssentialTerm Suite, aiming to make term life insurance more flexible, easier to convert, and simpler to buy, especially for customers with meaningful coverage needs. In addition, Prudential has tapped capital markets with two new senior unsecured note offerings, adding fixed-income firepower to its balance sheet. These steps, focused on both...
There is a lot to digest after ATRenew (NYSE:RERE) released its second quarter results. The buzz is real as investors have watched this company swing from losses a year ago to strong profitability, and this latest report serves up more than just good news. ATRenew not only delivered higher earnings and revenue than expected, but also doubled down with an upbeat outlook for its next quarter. For anyone evaluating what to do next with the stock, these events stand to reshape the conversation...
On August 18, 2025, Payoneer announced a partnership with Stripe to enhance its Online Checkout solution for SMBs, initially launching in key Asia Pacific markets such as China and Hong Kong and offering broader payment method access including Buy Now Pay Later options and digital wallets.
This move positions Payoneer to serve cross-border merchants with an expanded payment stack and improve customer conversion rates by leveraging Stripe’s technology.
We'll examine how integrating Stripe's...
Cimpress recently reported a fourth-quarter fiscal 2025 adjusted loss of US$1.02 per share, missing earnings estimates despite a 4.4% increase in year-over-year revenue and outlining plans to reduce leverage while expecting revenues to rise by 5-6% in fiscal 2026.
The company also projected fiscal 2026 net income of at least US$72 million and adjusted EBITDA of at least US$450 million, aiming to generate around US$310 million in operating cash and signaling a focus on improving profitability...
In late August 2025, Veracyte and University College London announced in Cell that the Decipher Prostate Genomic Classifier can predict which metastatic prostate cancer patients will benefit from docetaxel chemotherapy, while Veracyte also achieved full enrollment in its nightINGALE trial for the Percepta Nasal Swab lung cancer test.
These developments highlight Veracyte’s ongoing efforts to personalize cancer treatment decisions and expand the clinical utility of its genomic diagnostic...
Ramaco Resources announced in August 2025 that its Board of Directors declared a third-quarter stock dividend for Class B common shares, payable to shareholders of record as of September 5, 2025, with issuance occurring on September 19, 2025.
This dividend is being distributed as additional Class B shares, with the per-share allocation determined by dividing US$0.1918 by the closing price on the record date, highlighting an emphasis on equity-based returns for shareholders.
We'll examine how...
In August 2025, CommScope achieved record-breaking downstream speeds of 16.25 Gbps in a DOCSIS 4.0 network at the CableLabs interoperability event, showcasing results across multiple vendors and chipsets using its vCCAP Evo platform.
This achievement highlights the potential for DOCSIS 4.0 to offer fiber-like speeds and increased network flexibility without the high costs of deploying new infrastructure.
We'll examine how CommScope's DOCSIS 4.0 speed and interoperability breakthrough could...
Main Street Capital recently announced a dual listing on NYSE Texas and completed a US$350 million public offering of 5.40% notes due 2028.
The dual listing could expand the company’s reach among investors, while the new debt financing provides additional capital for future initiatives.
We'll explore how expanded access to capital from the new note offering may influence Main Street Capital's investment trajectory.
AI is about to change healthcare. These 28 stocks are working on everything...
